CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/67269/156096_B_5_7_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/67269/156091_A_1_4_rna_selected_60x60.jpg) | Mixed |
CELSR2 | Cadherin, EGF LAG seven-pass G-type receptor 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/13952/ihc_selected_60x60.jpg) | ![](/images/13952/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13952/32691_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CELSR3 | Cadherin, EGF LAG seven-pass G-type receptor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images/62866/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62866/144516_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images/22366/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14101/151887_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CHRM2 | Cholinergic receptor, muscarinic 2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/29795/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29795/62922_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CHRM3 | Cholinergic receptor, muscarinic 3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/24106/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/24106/52288_B_9_2_rna_selected_60x60.jpg) | Mixed |
CHRM4 | Cholinergic receptor, muscarinic 4 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/22444/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22444/55132_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CHRM5 | Cholinergic receptor, muscarinic 5 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/13172/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13172/31392_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CMKLR1 | Chemokine-like receptor 1 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/47865/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47865/109994_A_3_6_rna_selected_60x60.jpg) | Expressed in all |
CNR1 | Cannabinoid receptor 1 (brain) | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/5603/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5603/15927_A_5_3_rna_selected_60x60.jpg) | Tissue enhanced |
CNR2 | Cannabinoid receptor 2 (macrophage) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/9719/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9719/29978_B_3_7_rna_selected_60x60.jpg) | Group enriched |
CRHR1 | Corticotropin releasing hormone receptor 1 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CRHR2 | Corticotropin releasing hormone receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| ![](/images/46683/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46683/107105_B_9_8_rna_selected_60x60.jpg) | Mixed |
CX3CR1 | Chemokine (C-X3-C motif) receptor 1 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins
| ![](/images/32478/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32478/68384_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images/31991/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/31991/ihc_cell_selected_60x60.jpg) | ![](/images/31991/135677_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32017/139602_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR3 | Chemokine (C-X-C motif) receptor 3 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45942/139631_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
CXCR4 | Chemokine (C-X-C motif) receptor 4 | Cancer-related genes CD markers Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42432/123485_A_8_2_rna_selected_60x60.jpg) | Group enriched |
CXCR6 | Chemokine (C-X-C motif) receptor 6 | CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images/47591/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47591/107228_B_7_4_rna_selected_60x60.jpg) | Mixed |
CYSLTR1 | Cysteinyl leukotriene receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/10546/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10546/26409_B_7_7_rna_selected_60x60.jpg) | Mixed |
CYSLTR2 | Cysteinyl leukotriene receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/46528/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46528/106931_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
DRD1 | Dopamine receptor D1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/13393/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13393/30547_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
DRD2 | Dopamine receptor D2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/15691/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15691/132218_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
DRD3 | Dopamine receptor D3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Not detected |
DRD4 | Dopamine receptor D4 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Not detected |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/48930/ihc_cell_selected_60x60.jpg) | ![](/images/48930/118540_B_9_2_rna_selected_60x60.jpg) | Group enriched |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images/13774/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13774/33100_B_8_2_rna_selected_60x60.jpg) | Mixed |
EDNRB | Endothelin receptor type B | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/27546/ihc_selected_60x60.jpg) | ![](/images/17842/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27546/61969_B_3_7_rna_selected_60x60.jpg) | Mixed |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/25229/61162_A_3_1_rna_selected_60x60.jpg) | Mixed |
EMR1 | Egf-like module containing, mucin-like, hormone receptor-like 1 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| ![](/images/52809/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52809/119797_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
EMR2 | Egf-like module containing, mucin-like, hormone receptor-like 2 | CD markers G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
EMR3 | Egf-like module containing, mucin-like, hormone receptor-like 3 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| ![](/images/15638/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15638/37423_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
F2R | Coagulation factor II (thrombin) receptor | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| ![](/images/8973/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8973/22859_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
F2RL1 | Coagulation factor II (thrombin) receptor-like 1 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/12989/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12989/33495_B_9_2_rna_selected_60x60.jpg) | Mixed |
F2RL2 | Coagulation factor II (thrombin) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
F2RL3 | Coagulation factor II (thrombin) receptor-like 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
FFAR1 | Free fatty acid receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
FFAR2 | Free fatty acid receptor 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/23985/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23985/53479_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
FFAR3 | Free fatty acid receptor 3 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/44681/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44681/102940_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/42563/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42563/95411_B_9_1_rna_selected_60x60.jpg) | Group enriched |
FPR1 | Formyl peptide receptor 1 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/46550/ihc_selected_60x60.jpg) | ![](/images/61744/1413_D6_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/46550/105711_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
FPR2 | Formyl peptide receptor 2 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/29154/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29154/66364_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
FPR3 | Formyl peptide receptor 3 | G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Mixed |
FSHR | Follicle stimulating hormone receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
FZD1 | Frizzled class receptor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| ![](/images/13008/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/13008/32446_B_9_1_rna_selected_60x60.jpg) | Mixed |
FZD10 | Frizzled class receptor 10 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/14484/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/14484/34139_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
FZD2 | Frizzled class receptor 2 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| ![](/images/57667/ihc_selected_60x60.jpg) | ![](/images/57667/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57667/131005_B_7_7_rna_selected_60x60.jpg) | Mixed |
FZD3 | Frizzled class receptor 3 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| ![](/images/24995/ihc_selected_60x60.jpg) | ![](/images/42320/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/24995/57285_B_8_5_rna_selected_60x60.jpg) | Mixed |
FZD4 | Frizzled class receptor 4 | CD markers Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| ![](/images/42328/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42328/100004_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |